M
MoonLake Immunotherapeutics
NASDAQ:MLTX
MoonLake Immunotherapeutics
NASDAQ:MLTX
Price:
18.51
USD
5.65%
Market Closed
Market Cap:
$1.3B
Balance Sheet
Balance Sheet Decomposition
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics
Balance Sheet Decomposition is not available for
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics
Balance Sheet
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics
Currency: USD
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
8
|
40
|
451
|
0
|
|
| Cash |
8
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
40
|
451
|
0
|
|
| Short-Term Investments |
0
|
33
|
60
|
0
|
|
| Total Receivables |
1
|
4
|
1
|
26
|
|
| Other Current Assets |
0
|
0
|
2
|
0
|
|
| Total Current Assets |
10
|
77
|
514
|
474
|
|
| PP&E Net |
0
|
0
|
4
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
8
|
0
|
|
| Total Assets |
10
N/A
|
77
+694%
|
527
+585%
|
478
-9%
|
|
| Liabilities | |||||
| Accounts Payable |
1
|
0
|
1
|
9
|
|
| Accrued Liabilities |
5
|
7
|
8
|
13
|
|
| Short-Term Debt |
15
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
21
|
8
|
10
|
22
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
20
|
18
|
7
|
|
| Other Liabilities |
0
|
0
|
3
|
2
|
|
| Total Liabilities |
21
N/A
|
28
+31%
|
31
+10%
|
31
+0%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
0
|
0
|
|
| Retained Earnings |
54
|
81
|
117
|
236
|
|
| Additional Paid In Capital |
42
|
129
|
610
|
677
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
2
|
5
|
|
| Total Equity |
12
N/A
|
49
N/A
|
496
+914%
|
447
-10%
|
|
| Total Liabilities & Equity |
10
N/A
|
77
+694%
|
527
+585%
|
478
-9%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
37
|
39
|
60
|
63
|
|
Switch to:
Switch to:
See Also
Discover More
